A Controlled Trial of Gabapentin in Vulvodynia: Biological Correlates of Response.
Phase of Trial: Phase III
Latest Information Update: 07 May 2018
At a glance
- Drugs Gabapentin (Primary)
- Indications Vulvodynia
- Focus Therapeutic Use
- 07 May 2018 Primary endpoint (Tampon Test Pain Intensity) has not been met, according to the results published in the Obstetrics and Gynecology
- 07 May 2018 Results published in the Obstetrics and Gynecology
- 29 Apr 2016 Status changed from active, no longer recruiting to completed.